Impact of antibiotic therapy on the rate of negative test results for chronic endometritis: a prospective randomized control trial
rct
OA: closed
public-domain-us
AI-generated summary
In a randomized trial of women with chronic endometritis, fourteen days of antibiotic therapy significantly increased the rate of negative test results compared to no treatment, though it did not improve ongoing pregnancy or miscarriage rates.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To compare the rates of negative test results for chronic endometritis (CE) between subjects who did and did not receive antibiotic treatment.
DESIGN: Prospective, single-blind randomized controlled trial.
SETTING: Tertiary hysteroscopic center in a university teaching hospital.
PATIENT(S): A total of 132 women with CE confirmed with immunohistochemical study with CD138 epitope.
INTERVENTION(S): Women randomized to antibiotic therapy received oral levofloxacin 500 mg and tinidazole 1,000 mg daily for 14 days. Women randomized to the control group did not receive any treatment. A repeated endometrial biopsy was performed 4 to 8 weeks after the initial biopsy to determine whether CE was still present.
MAIN OUTCOME MEASURE(S): The rate of negative test results for CE (from positive to negative).
RESULT(S): The CE rate of negative test results in the treatment group (89.3%) after one course of antibiotic treatment was significantly higher than that in the control group (12.7%). Among subjects who attempted pregnancy, there was no significant difference in ongoing pregnancy rates and miscarriage rates between the treatment arm (43.2%, 5.4%) and the control arm (25.7%, 14.3%). Among subjects randomized, there was also no significant difference in ongoing pregnancy rates and miscarriage rates between the treatment arm (27.1%, 3.4%) and the control arm (16.4%, 9.1%).
CONCLUSION: A course of broad-spectrum oral antibiotic therapy for 14 days is effective in the treatment of CE in >89.8% of cases. However, it is not yet clear whether treatment improved pregnancy outcomes.
CLINICAL TRIAL IDENTIFICATION NUMBER: NCT02648698.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-09-06T09:34:12.023084+00:00
- pubmed
- last seen: 2026-05-13T22:24:55.077982+00:00
- unpaywall
- last seen: 2026-09-07T06:27:18.705824+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine